Year: 2022

REHOVOT, Israel and WILMINGTON, Del., Nov. 17, 2022 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers, today is announcing a poster presentation highlighting interim results from the Phase 2 segment / Part A of the RINGSIDE Pivotal Phase 2/3 clinical trial in desmoid tumors at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting, taking place in-person November 16-19 in Vancouver, Canada. The ongoing RINGSIDE Pivotal Phase 2/3 clinical trial is evaluating the investigational new drug AL102, a potent, selective, oral gamma-secretase inhibitor. Positive interim results from the Phase 2 segment of this study were previously presented at ESMO...

Bank Recognized as an Emerging DEI InfluencerProvident Bank receives The African American Chamber of Commerce of New Jersey and The New Jersey Chamber of Commerce DEI Trailblazer Award. Left to right: Thomas Bracken, President & CEO, New Jersey Chamber of Commerce; Patricia Teffenhart, Senior Vice President, Strategic Initiatives, New Jersey Chamber of Commerce; Carmen Gates, Director of Training and Community Initiatives, African American Chamber of Commerce of New Jersey (AACCNJ); Xavia Mitchell, First Vice President, Senior Diversity & HR Business Partner; Ferlanda Fox Nixon, Esq. Chief of Policy and External Affairs, African American Chamber of Commerce of New Jersey (AACCNJ); John Harmon, Founder, President & CEO, African American Chamber of Commerce of New Jersey (AACCNJ)ISELIN, N.J., Nov. 17, 2022 (GLOBE NEWSWIRE)...

Highlights:Incannex has engaged CMAX Clinical Research and Novotech CRO to undertake a bioavailability/bioequivalence (‘BA/BE’) study to assess the pharmacokinetics and tolerability of IHL-42X in 116 participants Incannex is well progressed in drafting an Investigational New Drug (‘IND’) Application for submission to the US Food and Drug Administration (‘FDA’) in Q1 of 2023 Once the IND is open, Incannex will commence pivotal, multi-site Phase 2/3 clinical trials investigating the effects of IHL-42X in patients with OSA over a 12-month period Phase 2/3 pivotal trials will include between 20 to 30 trial sites, including many in the United States. Sixty-three clinical trial sites have expressed interest in conducting the trial.MELBOURNE, Australia, Nov. 17, 2022 (GLOBE NEWSWIRE) — Incannex Healthcare Limited (Nasdaq: IXHL) (ASX:...

FREMONT, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, announced today that installers of Enphase© products in Belgium have seen growing deployments of Enphase Energy Systems™ powered by IQ© Microinverters and IQ™ Batteries. Enphase began shipping its microinverter products to Belgium more than a decade ago, and launched the IQ Battery in the country last year. Installers are increasingly turning to the Enphase Energy System to provide an all-in-one solution with its IQ Batteries and IQ Microinverters, allowing homeowners to store their energy for later use in their homes and avoid rising energy prices. “We strive to offer homeowners in Belgium home energy systems...

CHICAGO, IL, Nov. 17, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Epazz Inc. (OTC Pink: EPAZ), a mission-critical provider of metaverse solutions, blockchain cryptocurrency mobile apps, and cloud-based business software solutions, announced today that its On-site Remote Assist (OSRA) product integrated to the Metaverse technology would conduct first practical metaverse application on beta customers in Germany. Following Epazz’s newly acquired client contracts in Germany, the Epazz Metaverse with OSRA integration will deploy the software technology early in January next year.  TillerStack field management software, a member of Epazz Holdings, advances its revolutionary On-Site-Remote Assist product, a precursor to the Metaverse technology integration to real-world applications.  The Epazz’s Metaverse Technology, when...

As a certified partner, Linical will leverage Science 37’s Metasite™ to provide global access to patients beyond its existing brick-and-mortar site network RESEARCH TRIANGLE PARK, N.C. and OSAKA, Japan, Nov. 17, 2022 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq: SNCE), the industry-leading Metasite, and Linical Americas, a U.S. subsidiary of The Linical Group, a leading global contract research organization (CRO), today announced a partnership that will facilitate the deployment of decentralized clinical trial solutions—powered by Science 37—to Linical’s international clients, enabling patient access from virtually anywhere. As part of the collaboration, Linical will integrate Science 37’s virtual site capabilities into its network, to deliver faster, more inclusive, patient-centric trials to global research clients....

Designed with our patented and proven NiTiNOL technology, DynaNail Helix™ revolutionizes dynamic compression in foot & ankle fusionDynaNail Helix Image The new DynaNail Helix™ which is designed with Enovis’ patented and proven NiTiNOL technology.Wilmington, DE, Nov. 17, 2022 (GLOBE NEWSWIRE) — Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announces the introduction of the DynaNail Helix™, the latest addition to the DynaNail® family and Enovis’ expansive suite of foot and ankle products. DynaNail Helix is designed to achieve sustained dynamic compression for subtalar fusion with an innovative, anatomically friendly design and simple, screw-like insertion. Leveraging the same groundbreaking NiTiNOL compressive element technology from other DynaNail systems, the...

From a competitive wellness program to inclusive family support and beyond, DAVIDsTEA puts employees firstGPTW DavidsTea DAVIDsTEA officially certified as a Great Place to Work® for the second yearMONTRÉAL, Nov. 17, 2022 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) (“DAVIDsTEA” or the “Company”), a leading tea merchant in North America, is pleased to announce that after a thorough and independent analysis, the Company has, for the second year, been recognized as a Great Place to Work® by Great Place to Work Institute® Canada. This highly respected certification outlines the levels of trust employees have in their leaders, of pride they have in their work, and the extent to which they enjoy working with their colleagues. Based on direct feedback from employees provided as part of an extensive and anonymous survey about their...

The Name Change Reflects the Company’s Diversified Offerings Focusing on High-Power Computing (HPC) Applications DALLAS, Nov. 17, 2022 (GLOBE NEWSWIRE) — Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital ” or the “Company”), a designer, builder and operator of next-generation datacenters that provide power to blockchain infrastructure and support High-Performance Computing (HPC) applications, formally changed its name from “Applied Blockchain, Inc.” to “Applied Digital Corporation” effective as of November 17, 2022. The Company’s refreshed name more accurately reflects its mission, services and broader business offerings to serve customers that require large amounts of computing power for applications. While Applied Digital continues to be a premier provider of digital infrastructure for cryptocurrency...

Miami, FL, Nov. 17, 2022 (GLOBE NEWSWIRE) — Star8 Corp. (OTCPK: STRH) is excited to announce the completion of its previously announced binding Letter of Intent (“LOI”) to acquire Hyper 30 Data. Hyper 30 Data it a national technology integrator specializing in wireless solutions, fiber optics OPS/ISP, and network equipment. “Star8 is pleased to have closed on this deal and we are happy to officially welcome Hyper 30 Data to our family of companies,” said Mario Diez, Chief Executive Officer. “On behalf of the rest of the team at Star8, I want to express how very excited we are to have Hyper 30 Data onboard, and I know our company is better positioned for profitability thanks to this partnership.” Under the terms of agreement, Mario Diez is stepping down and Michael Knox is announced as the new CEO effective immediately. Star8...